Clinical Trials in Ohio

Showing 7261-7280 of 15,929 trials

Primary Diagnosis Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

NCT03991468

The primary objective of this study is to evaluate the safety and accuracy of the Hamamatsu WSI compared to those of the reference method (conventional light microscope (Glass)) under clinical use conditions as an aid for pathologists to view, review and diagnose digital images of surgical pathology slides. The primary endpoint is the indicator of major discordance in primary diagnosis between ground truth case diagnosis and case diagnosis by each modality, WSI and Glass, separately.

Pathology

Hamamatsu Photonics K.K.2,000 participantsStarted Mar 2019

St Louis, Missouri, United States • Albuquerque, New Mexico, United States • Cleveland, Ohio, United States +1 more locations

COMPLETEDPhase 232 miles

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

NCT04663282

The study is being conducted to evaluate the efficacy and safety of IND068 once daily (QD) in subjects with type 2 diabetes not adequately controlled with one or two oral antidiabetics compared to insulin degludec QD for 16 weeks.

Type 2 Diabetes

Jiangsu HengRui Medicine Co., Ltd.179 participantsStarted Feb 2021

Huntington Park, California, United States • Lincoln, California, United States • Lomita, California, United States +32 more locations

Primary Diagnosis Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Find Trials by Condition in Ohio

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

OLAParib COmbinations

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI

Evaluation of GLR2007 for Advanced Solid Tumors

Formula Tolerance of Term Infants

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia